Ann Coloproctol > Epub ahead of print |
|
Acknowledgments
The corresponding author would like to thank the team for the expertise and assistance in all aspects of the study and for the help in writing the manuscript, in particular Professor G. B. Cadiere for the correction of the draft and his advice.
Author contributions
Conceptualization:
Data curation:
Formal analysis:
Investigation:
Methodology:
Project administration:
Resources:
Software:
Supervision:
Validation:
Visualization:
Writing–original draft:
Writing–review & editing: all authors.
All authors read and approved the final manuscript.
Additional information
This study was previously shared as a preprint on Research Square (https://doi.org/10.21203/rs.3.rs-1392300/v2) and has since undergone peer review for publication in this journal.
Characteristic | Acute appendicitis | P-value | |
---|---|---|---|
Uncomplicated (n=161) | Complicated (n=107) | ||
Age (yr) | 33.5 (25.3–41.0) | 38.5 (27.0–52.0) | 0.018* |
Sex | 0.016* | ||
Female | 70 (43.5) | 31 (29.0) | |
Male | 91 (56.5) | 76 (71.0) | |
Nationality | 0.250 | ||
European | |||
Belgian | 59 (36.6) | 44 (41.1) | |
Non-Belgian | 42 (26.1) | 35 (32.7) | |
African | 34 (21.1) | 20 (18.7) | |
Middle Eastern | 7 (4.3) | 2 (1.9) | |
Asian | 5 (3.1) | 1 (0.9) | |
American | 9 (5.6) | 1 (0.9) | |
Unknown | 5 (3.1) | 4 (3.7) | |
Charlson Comorbidity Index | 0 (0–0) | 0 (0–1) | 0.017* |
History of abdominal surgery | 26 (16.1) | 14 (13.1) | 0.490 |
History of other surgeries | 18 (11.2) | 10 (9.3) | 0.631 |
Physical examination at admission | |||
Heart rate (bpm) | 87 (76.0–100.5) | 95 (81.0–108.0) | 0.007* |
Tachycardia (>100 bpm) | 48 (29.8) | 46 (43.0) | 0.027* |
Systolic arterial pressure (mmHg) | 125 (118–138) | 130 (118–140) | 0.286 |
Hypotension (<100 mmHg) | 8 (5.0) | 7 (6.5) | 0.583 |
Temperature (°C) | 36.9 (36.5–37.4) | 37.0 (36.7–37.5) | 0.039* |
Fever (>37.8 °C) | 19 (11.8) | 18 (16.8) | 0.243 |
Septic shock | 4 (2.5) | 2 (1.9) | >0.999 |
Blood test at admission | |||
C-reactive protein (g/dL) | 29.2 (6.5–101.0) | 97.5 (29.6–188.3) | <0.001* |
White blood cell count (/mm3) | 13,460 (8,216–16,170) | 15,720 (12,040–18,500) | 0.001* |
Surgical intervention | 0.020* | ||
Appendicectomy | 158 (98.1) | 99 (92.5) | |
Cecectomy | 1 (0.6) | 7 (6.5) | |
Ileocecal resection | 2 (1.2) | 1 (0.9) | |
Laparoscopic procedure | 156 (96.9) | 91 (85.0) | <0.001* |
Drainage | 83 (51.6) | 84 (78.5) | <0.001* |
Periappendicular | 42 (26.1) | 59 (55.1) | <0.001* |
Pelvic | 63 (39.1) | 57 (53.3) | 0.025* |
Other localizations | 6 (3.7) | 4 (3.7) | >0.999 |
Variable | Acute appendicitis | P-value | |
---|---|---|---|
Uncomplicated (n=161) | Complicated (n=107) | ||
Culture | 0.016* | ||
Negative | 75 (46.6) | 34 (31.8) | |
Positive | 86 (53.4) | 73 (68.2) | |
Bacterial isolation | |||
Gram-negative | 76 (47.2) | 65 (60.7) | 0.030* |
Gram-positive | 26 (16.1) | 24 (22.4) | 0.196 |
Strict anaerobes | 18 (11.2) | 22 (20.6) | 0.035* |
First-line antibiotic treatment | 0.013* | ||
None | 7 (4.3) | 2 (1.9) | |
Monotherapy | 154 (95.7) | 100 (93.5) | |
Combined therapy | 0 (0) | 5 (4.7) | |
First-line antibiotic treatment | |||
None | 7 (4.3) | 2 (1.9) | 0.098 |
Amoxicillin/clavulanic acid | 152 (94.4) | 96 (89.7) | |
Amoxicillin/clavulanic acid-metronidazole | 0 (0) | 1 (0.9) | |
Amoxicillin/clavulanic acid-ornidazole | 0 (0) | 1 (0.9) | |
Cefuroxime-metronidazole | 0 (0) | 1 (0.9) | |
Cefuroxime-ornidazole | 0 (0) | 2 (1.9) | |
Clindamycin | 2 (1.2) | 1 (0.9) | |
Levofloxacin | 0 (0) | 1 (0.9) | |
Piperacillin/tazobactam | 0 (0) | 2 (1.9) | |
Resistance to first-line antibiotic treatment | 27 (16.8) | 10 (9.3) | 0.084 |
Second-line antibiotic treatment | 0.889 | ||
None | 132 (80.2) | 86 (80.4) | |
Monotherapy | 11 (6.8) | 9 (8.4) | |
Combined therapy | 18 (11.2) | 12 (11.2) | |
Second-line antibiotic treatment | |||
None | 132 (82.0) | 86 (80.4) | 0.763 |
Amoxicillin/clavulanic acid-metronidazole | 0 (0) | 1 (0.9) | |
Amoxicillin/clavulanic acid-ornidazole | 6 (3.7) | 4 (3.7) | |
Amoxicillin/clavulanic acid-doxycycline | 1 (0.6) | 0 (0) | |
Cefuroxime-metronidazole | 1 (0.6) | 0 (0) | |
Cefuroxime-ornidazole | 1 (0.6) | 0 (0) | |
Ceftriaxone-doxycycline | 2 (1.2) | 0 (0) | |
Doxycycline | 0 (0) | 1 (0.9) | |
Levofloxacin | 3 (1.9) | 2 (1.9) | |
Levofloxacin-ornidazole | 4 (2.5) | 4 (3.7) | |
Ciprofloxacin-ornidazole | 3 (1.9) | 3 (2.8) | |
Piperacillin/tazobactam | 8 (5.0) | 5 (4.7) | |
Ornidazole | 0 (0) | 1 (0.9) | |
Resistance to second-line antibiotic treatment | 0 (0) | 1 (0.9) | 0.399 |
Third-line antibiotic treatment | 0.337 | ||
None | 159 (98.8) | 103 (96.3) | |
Monotherapy | 1 (0.6) | 1 (0.9) | |
Combined therapy | 1 (0.6) | 1 (0.9) | |
Third-line antibiotic treatment | 0.552 | ||
None | 159 (98.8) | 103 (96.3) | |
Levofloxacin-ornidazole | 1 (0.6) | 1 (0.9) | |
Ciprofloxacin-ornidazole | 0 (0) | 1 (0.9) | |
Piperacillin/tazobactam | 1 (0.6) | 1 (0.9) | |
Ceftazidime-vancomycin-ornidazole-anidulafungin | 0 (0) | 1 (0.9) | |
Resistance to third-line antibiotic treatment | 0 (0) | 0 (0) | >0.999 |
Antibiotic treatment duration (day) | 5.0 (2–7) | 5.5 (3–7) | 0.002* |
Antibiotic treatment >1 wk | 19 (11.8) | 22 (20.6) | 0.051 |
Variable | Acute appendicitis | P-value | |
---|---|---|---|
Uncomplicated (n = 161) | Complicated (n = 107) | ||
Morbidity | 11 (6.8) | 21 (19.6) | 0.002* |
Clavien-Dindo classification of 30-day complications | 0.012* | ||
Grade I | 2 (1.2) | 6 (5.6) | |
Grade II | 4 (2.5) | 9 (8.4) | |
Grade III | 5 (3.1) | 6 (5.6) | |
Reintervention | 3 (1.9) | 4 (3.7) | 0.442 |
Specific complication | |||
Postoperative ileus | 4 (2.5) | 6 (5.6) | 0.204 |
Acute kidney injury | 0 (0) | 1 (0.9) | 0.399 |
Bacteremia | 0 (0) | 1 (0.9) | 0.399 |
Surgical site infection | 8 (5.0) | 14 (13.1) | 0.018* |
Cecal perforation | 1 (0.6) | 1 (0.9) | >0.999 |
Blood test at 48 hr | |||
C-reactive protein (mg/dL) | 111.9 (28.9–215.7) | 202.4 (96.6–316.0) | 0.001* |
White blood cell count (/mm3) | 8,660 (6,715–10,980) | 8,695 (6,335–12,052) | 0.447 |
Hospital stay (day) | 3 (2–5) | 5 (3–6) | <0.001* |
Risk factor | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | |
Age (yr) | 1.022 (1.005–1.039) | 0.009* | 1.022 (1.005–1.039) | 0.009* |
Sex | 0.017* | - | - | |
Female | Reference | |||
Male | 1.887 (1.120–3.174) | |||
Nationality | 0.249 | - | - | |
European (Belgian) | Reference | |||
European (non-Belgian) | 1.117 (0.617–2.025) | |||
African | 0.789 (0.401–1.551) | |||
Middle Eastern | 0.383 (0.076–1.934) | |||
Asian | 0.268 (0.030–2.378) | |||
American | 0.149 (0.018–1.120) | |||
Charlson Comorbidity Index | 1.459 (1.114–1.911) | 0.006* | 1.333 (1.003–1.771) | 0.048* |
History of abdominal surgery | 0.782 (0.782–1.576) | 0.491 | - | - |
History of other surgeries | 0.819 (0.363–1.850) | 0.631 | - | - |
Physical examination at admission | - | - | ||
Heart rate (bpm) | 1.018 (1.004–1.033) | 0.010* | ||
Tachycardia (>100 bpm) | 1.775 (1.066–2.958) | 0.028* | ||
Systolic arterial pressure (mmHg) | 1.005 (0.990–1.019) | 0.54 | ||
Hypotension (<100 mmHg) | 1.339 (0.471–3.807) | 0.584 | ||
Temperature (°C) | 1.383 (0.994–1.924) | 0.054 | ||
Fever (>37.8 °C) | 1.512 (0.753–3.035) | 0.245 | ||
Septic shock | 0.748 (0.135–4.155) | 0.740 | ||
Blood test at admission | ||||
C-reactive protein (g/dL ) | 1.005 (1.002–1.007) | <0.001* | - | - |
White blood cell count (/mm3) | 1.00008 (1.00003–1.00014) | <0.001* | 1.00007 (1.00001–1.00013) | 0.027* |
Surgical intervention | - | - | ||
Appendicectomy | Reference | |||
Cecectomy | 11.172 (1.354–92.174) | 0.025* | ||
Ileocecal resection | 0.798 (0.071–8.916) | 0.855 | ||
Laparoscopic procedure | 0.182 (0.065–0.514) | 0.001* | 0.218 (0.073–0.648) | 0.006* |
Drainage | 3.432 (1.970–5.980) | <0.001* | 2.571 (1.421–4.653) | 0.002* |
Culture | 0.016* | - | - | |
Negative | Reference | |||
Positive | 1.872 (1.123–3.122) | |||
Bacterial isolation | - | - | ||
Gram-negative | 1.731 (1.054–2.843) | 0.030* | ||
Gram-positive | 1.501 (0.809–2.787) | 0.198 | ||
Strict anaerobes | 2.056 (1.043–4.052) | 0.037* | ||
First-line antibiotic treatment | 0.870 (0.704–1.075) | 0.197 | - | - |
Resistance to first-line antibiotic treatment | 0.512 (0.237–1.106) | 0.089 | - | - |
Bacterial specific isolation | - | - | ||
Escherichia coli | 1.550 (0.945–2.543) | 0.083 | ||
Klebsiella spp. | 0.854 (0.244–2.993) | 0.806 | ||
Bacteroides spp. | 2.879 (1.163–7.124) | 0.022* | ||
Pseudomonas aeruginosa | 1.741 (0.683–4.439) | 0.246 | ||
Enterococcus spp. | 1.003 (0.276–3.643) | 0.996 | ||
Streptoccocus anginosus group | 2.102 (1.016–4.347) | 0.045* |
Routine Intraoperative Bacterial Culture May Be Needed in Complicated Appendicitis2020 June;36(3)
Diagnostic Value of C-reactive Protein in Complicated Appendicitis2011 June;27(3)